title: Vaccination with recombinant Clostridium perfringens toxoids α and β promotes elevated antepartum and passive humoral immunity in swine.
abstract: Due to the increasingly restricted use of antimicrobials in animal production systems, the prevention and control of Clostridium perfringens type A- and C-induced diarrhea in piglets should be based on passive immunization via the prepartum vaccination of sows. Given the current obstacles in the production of conventional clostridial vaccines, the use of recombinant proteins has been considered to represent a promising alternative. In the present study, the neutralizing antibody response of immunized sows and their litters to a bivalent vaccine containing the C. perfringens recombinant toxoids alpha (rTA) and beta (rTB) produced in Escherichia coli was assessed. Rabbits (n=8) and pregnant sows (n=7) were immunized with 200μg of each recombinant antigen using Al(OH)3 as adjuvant. The alpha and beta antitoxin titer detected in the rabbits' serum pool was 9.6 and 20.4IU/mL, respectively. The mean alpha and beta antitoxin titers in the sows' sera were 6.0±0.9IU/mL and 14.5±2.2IU/mL, and the corresponding individual coefficients of variation (CV) were 16.04% and 14.91%, respectively. The mean alpha and beta antitoxin titers in the litters' serum pools were 4.2±0.4IU/mL and 10.9±1.7IU/mL, and the CV between litters was 9.23% and 9.85%, respectively. The results showed that the rTA and rTB proteins produced and tested in the present study induced an immune response and can be regarded as candidates for the development of a commercial vaccine against C. perfringens type A- and C-induced diarrhea in pigs.
authors.affiliation: Escola de Veterinária, Universidade Federal de Minas Gerais, CP 567, CEP 30123-970, Belo Horizonte, MG, Brazil.
authors.forename: Felipe M
authors.initials: FM
authors.lastname: Salvarani
authors.forename: Fabricio R
authors.initials: FR
authors.lastname: Conceição
authors.forename: Carlos E P
authors.initials: CE
authors.lastname: Cunha
authors.forename: Gustavo M S G
authors.initials: GM
authors.lastname: Moreira
authors.forename: Prhiscylla S
authors.initials: PS
authors.lastname: Pires
authors.forename: Rodrigo O S
authors.initials: RO
authors.lastname: Silva
authors.forename: Guilherme G
authors.initials: GG
authors.lastname: Alves
authors.forename: Francisco C F
authors.initials: FC
authors.lastname: Lobato
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D057134:Antibodies, Neutralizing; D001428:Bacterial Vaccines / Q000235:genetics / Q000276:immunology* / Q000494:pharmacology; D003015:Clostridium Infections / Q000517:prevention & control / Q000662:veterinary; D003967:Diarrhea / Q000382:microbiology / Q000517:prevention & control / Q000662:veterinary; D004926:Escherichia coli / Q000235:genetics; D005260:Female; D056724:Immunity, Humoral / Q000276:immunology*; D007116:Immunization, Passive; D011247:Pregnancy; D011817:Rabbits; D013552:Swine; D013553:Swine Diseases / Q000276:immunology* / Q000517:prevention & control; D014121:Toxoids / Q000235:genetics / Q000276:immunology*; D016896:Treatment Outcome
chemical_list: D057134:Antibodies, Neutralizing; D001428:Bacterial Vaccines; C035454:Clostridium perfringens toxoid; D014121:Toxoids
keywords: Alpha toxin; Beta toxin; Clostridium perfringens; Neonatal pig diarrhea; Passive immunity; Recombinant vaccine